Literature DB >> 2038720

Immunosuppressive drugs in immune and inflammatory ocular disease.

R Hemady1, J Tauber, C S Foster.   

Abstract

Advances in immunology, particularly ocular immunology, have been accompanied by the emergence of safer, more specific immunosuppressive drugs, notably, cyclophosphamide, chlorambucil, methotrexate, azathioprine, cyclosporine A, bromocriptine, dapsone, and colchicine. These drugs have become an important, and often essential, part of the ophthalmologist's armamentarium against inflammatory and immune-mediated ocular diseases. In order to better acquaint the ophthalmologist with the properties of the most commonly used immunosuppressive drugs, we review the literature and relate our own experience with these agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2038720     DOI: 10.1016/0039-6257(91)90186-j

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Management of chronic uveitis.

Authors:  P J McCluskey; H M Towler; S Lightman
Journal:  BMJ       Date:  2000-02-26

Review 3.  Management of uveitis in pediatric patients: special considerations.

Authors:  Justine R Smith
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  A Heiligenhaus; H Michels; C Schumacher; I Kopp; U Neudorf; T Niehues; H Baus; M Becker; B Bertram; G Dannecker; C Deuter; I Foeldvari; M Frosch; G Ganser; M Gaubitz; G Gerdes; G Horneff; A Illhardt; F Mackensen; K Minden; U Pleyer; M Schneider; N Wagner; M Zierhut
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

5.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

6.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

7.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

Review 8.  Treatment of ocular inflammation in children.

Authors:  Sunil M Thadani; C Stephen Foster
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Cyclosporin A therapy in refractory non-infectious childhood uveitis.

Authors:  D J Kilmartin; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

10.  Corneoscleral graft in Mooren's ulcer: a case report.

Authors:  Mauro Cellini; Michela Fresina; Ernesto Strobbe; Corrado Gizzi; Emilio C Campos
Journal:  Cases J       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.